Data for ST003069   

(Analysis AN005026): Average values per metabolite and experimental factor (Units:µM)

Metabolite structureAll dataF1F2F3F4F5F6F7F8F9F10F11F12
AA
2.66 2.88 3.77 3.91 3.77 2.50 3.17 2.92 5.16 4.25 5.16 4.22
AconAcid
6.43 6.17 5.88 6.87 5.88 6.71 0.74 0.69 0.74 0.54 0.74 0.70
CA
0.04 0.08 0.03 0.06 0.03 0.06 0.04 0.09 0.03 0.06 0.03 0.05
Cystine
66.03 56.70 62.60 70.20 62.60 69.00 69.88 61.45 68.50 64.50 68.50 72.05
DHA
1.74 1.86 2.59 2.15 2.59 1.76 1.86 1.89 4.04 2.68 4.04 1.18
DHEAS
3.85 6.61 3.76 7.12 3.76 7.37 4.38 7.33 4.30 7.18 4.30 7.41
FA(18:1)
53.98 78.10 142.85 115.50 142.85 86.35 64.38 82.90 155.55 102.30 155.55 84.70
FA(18:2)
11.95 16.35 27.50 23.80 27.50 21.85 13.72 17.25 28.80 21.95 28.80 20.45
FA(20:1)
0.66 0.80 1.56 1.18 1.56 1.14 0.74 0.96 1.69 1.09 1.69 1.14
FA(20:2)
0.31 0.42 0.87 0.62 0.87 0.42 0.38 0.47 0.93 0.55 0.93 0.43
FA(20:3)
0.20 0.25 0.41 0.37 0.41 0.32 0.23 0.27 0.43 0.35 0.43 0.30
GCA
0.24 0.10 0.38 0.21 0.38 0.12 0.25 0.11 0.41 0.24 0.41 0.13
GCDCA
0.99 0.18 0.66 0.47 0.66 0.79 0.96 0.21 0.73 0.49 0.73 0.84
GLCAS
0.14 0.08 0.24 0.16 0.24 0.28 0.15 0.09 0.28 0.18 0.28 0.40
GUDCA
0.25 0.06 0.15 0.07 0.15 0.06 0.25 0.06 0.17 0.07 0.17 0.06
Ind-SO4
2.73 4.24 3.10 4.08 3.10 3.67 2.96 4.86 3.52 4.13 3.52 3.50
Lac
1921.25 1630.00 1822.00 1571.50 1822.00 2126.00 2692.25 2814.00 2648.25 2424.50 2648.25 3001.50
p-Cresol-SO4
9.14 21.22 13.32 16.64 13.32 7.89 9.71 24.57 15.90 19.42 15.90 7.67
TCA
0.05 0.01 0.05 0.03 0.05 0.01 0.05 0.01 0.06 0.04 0.06 0.01
TCDCA
0.31 0.02 0.14 0.06 0.14 0.05 0.28 0.03 0.15 0.06 0.15 0.06
TDCA
0.11 0.00 0.08 0.01 0.08 0.02 0.14 0.00 0.07 0.01 0.07 0.02

Factors:

F1Sample material:Plasma | Treatment:after_Aspirin | Sex:F
F2Sample material:Plasma | Treatment:after_Aspirin | Sex:M
F3Sample material:Plasma | Treatment:before_Aspirin | Sex:F
F4Sample material:Plasma | Treatment:before_Aspirin | Sex:M
F5Sample material:Plasma | Treatment:Plasma | Sex:F
F6Sample material:Plasma | Treatment:Plasma | Sex:M
F7Sample material:Serum | Treatment:after_Aspirin | Sex:F
F8Sample material:Serum | Treatment:after_Aspirin | Sex:M
F9Sample material:Serum | Treatment:before_Aspirin | Sex:F
F10Sample material:Serum | Treatment:before_Aspirin | Sex:M
F11Sample material:Serum | Treatment:Serum | Sex:F
F12Sample material:Serum | Treatment:Serum | Sex:M
  logo